Titan Medical Releases SPORT(TM) Video Clip-"SPORT Tackles Complex Surgical Tasks"

Titan Medical Inc. ("Titan" or the "Company") (TSX VENTURE:TMD)(OTCQX:TITXF) is
pleased to provide an update on the ongoing progress of the Single Port Orifice
Robotic Technology (SPORT(TM)) Surgical System. Today, the Company is releasing
a video clip demonstrating electrocautery, tissue suturing and instrument swaps.
The video may be viewed at www.titanmedicalinc.com.  


"This video depicts a significant advancement of our SPORT(TM) Surgical System,"
said John Hargrove, Chairman and CEO. "SPORT(TM) now has instrumentation that
can deliver electrocautery. Additionally, the system and instrumentation are
capable of tissue suturing, considered to be one of the most complex maneuvers
performed in any minimally invasive procedure. We are very proud of these
accomplishments and remain committed to our development timeline." 


SPORT(TM) Surgical System testing and development is continuing and remains on
schedule. The video and related information will be presented at Titan Medical's
Annual General Meeting on May 21, 2014 at 2 PM EST. 


About Titan Medical Inc. 

Titan Medical Inc. is a Canadian public company (TSX VENTURE:TMD)(OTCQX:TITXF)
focused on the design and development of a robotic surgical system for
application in minimally invasive surgery ("MIS"). The Company's robotic
surgical system, currently under development, comprises a surgeon-controlled
robotic platform that includes a 3D vision system and interactive instruments
for performing MIS procedures, and a surgeon workstation that provides the
surgeon with an interface to the robotic platform for controlling the
interactive instruments and providing a 3D endoscopic view of inside a patient's
body during MIS procedures. The robotic surgical system is being designed to
expand robotic surgery into areas of surgical specialties and simple and complex
procedures that are currently under-serviced, and to allow surgeons to perform
procedures within small to medium size surgical spaces such as general surgery
and cholecystectomy. For more information, visit the Company's website at
www.titanmedicalinc.com.


Forward-Looking Statements 

This news release contains "forward-looking statements" which reflect the
current expectations of management of the Company's future growth, results of
operations, performance and business prospects and opportunities. Wherever
possible, words such as "may", "would", "could", "will", "anticipate",
"believe", "plan", "expect", "intend", "estimate", "potential for" and similar
expressions have been used to identify these forward-looking statements. These
statements reflect management's current beliefs with respect to future events
and are based on information currently available to management. Forward-looking
statements involve significant risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or achievements to
be materially different from any future results, performance or achievements
that may be expressed or implied by such forward-looking statements, including,
without limitation, those listed in the "Risk Factors" section of the Company's
Annual Information Form dated April 4, 2014 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties materialize,
or should assumptions underlying the forward looking statements prove incorrect,
actual results, performance or achievements may vary materially from those
expressed or implied by the forward-looking statements contained in this news
release. These factors should be considered carefully and prospective investors
should not place undue reliance on the forward-looking statements. Although the
forward-looking statements contained in the news release are based upon what
management currently believes to be reasonable assumptions, the Company cannot
assure prospective investors that actual results, performance or achievements
will be consistent with these forward-looking statements.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Titan Medical Inc.
John Hargrove
Chairman and Chief Executive Officer
[phone]  (ext. 151)
[e-mail]
www.titanmedicalinc.com


Investor Relations
Beverly Brooks
[phone]
[e-mail]